Sign in

NCT06051110Completed

Individual Patient Data Meta-analysis on Prehospital Risk Assessment in Patients Suspected of Non-ST-segment Elevation Acute Coronary Syndrome

Source: ClinicalTrials.gov · Last updated 18 Mar 2026

Brief summary (registry, in English)

Patients with a non-ST-segment elevation acute coronary syndrome (NSTE-ACS) are currently transported and admitted to the nearest emergency department (ED) for risk stratification, diagnostic workup, and treatment. Recently, several prospective studies have been performed on the diagnostic performance of point-of-care (POC)-troponin and combined risk scores (CRS) for pre-hospital risk assessment and triage of NSTE-ACS patients. Also the first intervention trials on triage decisions based on POC troponin and CRS have been performed. Initial results are indicating that prehospital triage based on these diagnostic tools is feasible and safe, although sample sizes were relatively small and underpowered to detect differences in major adverse cardiac events (MACE). The objective of this individual patient data meta-analysis is to determine the diagnostic performance of POC troponin and combined risk scores for prehospital risk assessment and triage in suspected NSTE-ACS patients.

Status (registry)
Completed
Study type
Interventional
Enrollment
5239 (actual)
First submitted
4 Sept 2023
Start date
1 Oct 2023
Primary completion date
1 Dec 2024
Lead sponsor
Catharina Ziekenhuis Eindhoven
NCT number
NCT06051110

What you commit to

  • Study type: Interventional
  • Participants enrolled: 5239
  • From 1 Oct 2023 to the primary completion date, 1 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Enrolling only a specific subpopulation from the general ACS population
  • Studies with less than 100 patients
  • Studies enrolling only patients with STEMI.
  • Studies published before 1995 / the pre-troponin era
  • Studies performed by general practitioners.

Who the study is looking for

  • Patients suspected for NSTE-ACS;
  • Prospective study
  • Original data
  • Presenting prehospital (EMS)
  • Prehospital risk assessment using at least POC-troponin, performed and analyzed by EMS.
  • Outcome data available on in-hospital ACS or MACE within 30 days.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Catharina Hospital Eindhoven
Coordinator of this site? Confirm its status
EindhovenNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.